🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

191 notícias encontradas para "drug"
Just one exposure to cocaine alters mouse brain cells for 2 weeks, research reveals
Researchers studying the impact of cocaine in mice have found that just one exposure to the drug can create changes in brain cells that persist for at least two weeks. Their findings were presented at the Federation of European Neuroscience Societies (FENS) Forum 2026.
Aid for brain-bleed recovery receives expedited review
A noninvasive neuromodulation technology has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for reducing a dangerous narrowing of blood vessels in the brain that can follow a brain bleed from a ruptured aneurysm.
FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Drug candidate treats severe fatty liver disease by protecting the gut in animal models
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.
Could these tiny organs save millions of lives?
Could these tiny organs save millions of lives?
If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it become a cycle of educated guesswork: trying one drug combination, waiting, scanning? If the tumor doesn't respond, trying something else. In the meantime,
Promising medication combination to treat an 'undruggable' type of lung cancer
Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for thousands of patients with lung cancer driven by a rare type of KRAS mutation, offering hope for patients worldwide with this difficult-to-treat subtype of
Clinical trial offers strong evidence that nerve blocks can cut opioid use after cardiac s
A clinical trial led by St. Michael's Hospital researchers found that using nerve blocks, an anesthesia technique to numb targeted areas of the body, significantly reduced opioid use after cardiac surgery—findings the authors say could reshape how the potentially addictive drugs
Foto: Abhishek  Navlakha / Pexels
Medicare GLP-1 Bridge program may lead to bone problems
The new Medicare GLP-1 Bridge program offers broader, more affordable access to weight loss drugs to address the growing obesity crisis. But there's a catch when it comes to bone health.
Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients wit
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival outcomes, by treating them with the antibody-drug conju
Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-appro
Five-agent AI team could speed clinical trial design using real-world patient records
Five-agent AI team could speed clinical trial design using real-world patient records
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators. The findings, published in N
New drug against metastatic prostate cancer made entirely from human proteins
A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published in the journal Signal Transduction and Targeted Thera